Abstract

Background: Janus kinase (JAK) inhibitors represent a novel therapeutic class for treatment of inflammatory bowel disease.

Tags

Adverse Effects, Janus kinase inhibitors, Anti-Inflammatory Agents, Inflammatory Bowel Disease, IBD, Drug Therapy, therapeutic use, Treatment Outcome

Read More